ibritumomab tiuxetan

Ligand id: 6777

Name: ibritumomab tiuxetan

Immunopharmacology Disease
Disease X-Refs Comment References
non-Hodgkin lymphoma Disease Ontology: DOID:0060060
OMIM: 605027
Approved specifically for relapsed or refractory, low grade or transformed B cell non-Hodgkin's lymphoma can be treated with Yttrium-90 labelled ibritumomab tiuxetan.